- Home
- FBRT vs RLAY Comparison
FBRT vs RLAY Comparison
Compare FBRT & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRT
- RLAY
- Stock Information
- Founded
- FBRT 2012
- RLAY 2015
- Country
- FBRT United States
- RLAY United States
- Employees
- FBRT N/A
- RLAY N/A
- Industry
- FBRT Real Estate Investment Trusts
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FBRT Real Estate
- RLAY Health Care
- Exchange
- FBRT Nasdaq
- RLAY Nasdaq
- Market Cap
- FBRT 918.2M
- RLAY 803.4M
- IPO Year
- FBRT 1985
- RLAY 2020
- Fundamental
- Price
- FBRT $10.72
- RLAY $5.75
- Analyst Decision
- FBRT Strong Buy
- RLAY Strong Buy
- Analyst Count
- FBRT 4
- RLAY 8
- Target Price
- FBRT $14.75
- RLAY $17.25
- AVG Volume (30 Days)
- FBRT 544.2K
- RLAY 1.6M
- Earning Date
- FBRT 11-03-2025
- RLAY 11-05-2025
- Dividend Yield
- FBRT 13.25%
- RLAY N/A
- EPS Growth
- FBRT 18.52
- RLAY N/A
- EPS
- FBRT 0.98
- RLAY N/A
- Revenue
- FBRT $207,768,000.00
- RLAY $8,355,000.00
- Revenue This Year
- FBRT $28.63
- RLAY $27.33
- Revenue Next Year
- FBRT $1.25
- RLAY $8.87
- P/E Ratio
- FBRT $10.94
- RLAY N/A
- Revenue Growth
- FBRT 16.05
- RLAY N/A
- 52 Week Low
- FBRT $9.79
- RLAY $1.78
- 52 Week High
- FBRT $13.58
- RLAY $7.07
- Technical
- Relative Strength Index (RSI)
- FBRT 36.62
- RLAY 78.08
- Support Level
- FBRT $10.65
- RLAY $5.17
- Resistance Level
- FBRT $11.20
- RLAY $5.72
- Average True Range (ATR)
- FBRT 0.17
- RLAY 0.28
- MACD
- FBRT -0.07
- RLAY 0.08
- Stochastic Oscillator
- FBRT 10.26
- RLAY 98.35
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States. Its segments include the real estate debt business; the real estate securities business; the real estate owned business; and the commercial real estate conduit business.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).